Sign in

CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851623397
Phone
617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
  1. 8-K Event Shareholder vote results
  2. 4 Derivatives Options or other derivatives
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 8-K Event Material agreement · Regulation FD disclosure
  7. 424B5 Offering Prospectus
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 424B5 Offering Prospectus
  10. DEF 14A Proxy Proxy Statement
  11. PRE 14A Proxy Proxy Statement (Preliminary)
  12. 8-K Event Results of operations · Executive or director change
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 8-K Event Regulation FD disclosure
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. 4 Derivatives Options or other derivatives
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 3 of 19 · 361 filings